Jack Schalken

Jack A Schalken PhD (54) was trained as biochemist at the Radboud University Nijmegen, where he also obtained his PhD degree (1987). He did his post doc with Dr John T Isaacs at Johns Hopkins Hospital (Baltimore, MD). Since then he is director of urological research at the Radboud University Medical Center and his lab is housed in the Nijmegen Center for Molecular Life Sciences (www.ncmls.ru.nl) a state of the art research facility for molecular- and cell biology. In 1996 Dr Schalken was appointed as full professor of experimental oncology at the University of Utrecht. Since 2001 he is professor of experimental urology at the Radboud University (Nijmegen). He is (co-) author on > 310 peer reviewed publications and 75 chapters. His research focuses on the molecular- and cellular basis of GU cancer, particularly prostate cancer. Specific themes • Unravelling the mechanism of GU cancer invasion/cadherin switching • Molecular diagnostics of prostate cancer; PCA3. Professor Schalken’s team discovered the recently introduced PrCa specific biomarker. • Cancer stem/initiating cells • Targeted therapy in GU cancer

Biography Updated on 16 April 2013

Scholarly Contributions [Data Provided by ]